Octreotide stimulates insulin-like growth factor binding protein-1: a novel mechanism of drug action on acromegaly.
Melmed
S
S
Department of Endocrinology and Metabolism, Cedars-Sinai Medical Center-UCLA 90048.
D000172:Acromegaly / Q000188:drug therapy / Q000378:metabolism* / Q000503:physiopathology; D002352:Carrier Proteins / Q000096:biosynthesis*; D006801:Humans; D018970:Insulin-Like Growth Factor Binding Protein 1; D007334:Insulin-Like Growth Factor I / Q000037:antagonists & inhibitors; D015282:Octreotide / Q000494:pharmacology* / Q000627:therapeutic use; D013002:Somatomedins / Q000096:biosynthesis*
D002352:Carrier Proteins; D018970:Insulin-Like Growth Factor Binding Protein 1; D013002:Somatomedins; D007334:Insulin-Like Growth Factor I; D015282:Octreotide